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Abstract
We compare the known retinitis pigmentosa (RP) mutations in rhodopsin with mutational data obtained for the complement factor
5a receptor (C5aR), a member of the rhodopsin-like family of G protein-coupled receptors (GPCRs). We have performed genetic analy-
ses that deWne residues that are required for C5aR folding and function. The cognate residues in rhodopsin are not preferentially mutated
in RP, suggesting that the predominant molecular defect in RP involves more than simple misfolding or inactivation. Energy calculations
are performed to elucidate the structural eVects of the RP mutations. Many of these mutations speciWcally disrupt the environment of the
retinal prosthetic group of rhodopsin, and these do not correspond to essential residues in C5aR. This may be because a retinal group is
present in rhodopsin but not in C5aR. Another subset of RP mutations is more generally important for receptor structure, and these
mutations correlate with essential residues of C5aR.
© 2006 Elsevier Ltd. All rights reserved.
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G protein-coupled receptors (GPCRs) are cell-surface
receptors containing seven transmembrane helices sepa-
rated by intra- and extra-cellular loops. Upon ligand bind-
ing, GPCRs trigger a cascade of downstream events (Neves,
Ram, & Iyengar, 2002; Hamm, 2001). The estimated 948
GPCRs in the human genome (Takeda, Kadowaki, Haga,
Takaesu, & Mitaku, 2002) include sensors for endogenous
polypeptide and small-molecule hormones, environmental
chemicals such as odorants, and light. As GPCRs cannot
readily be reverse-engineered to determine their precise
mechanism of action, a wide variety of structural and
* Corresponding author.
E-mail address: baranskt@im.wustl.edu (T.J. Baranski).0042-6989/$ - see front matter © 2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2006.07.010genetic studies have been used to explore this important
class of proteins (see for example Wess (1999)).
The functioning of GPCRs relies upon a complex chain
of events. The polypeptide must be synthesized and translo-
cated into the endoplasmic reticulum, where it must be
folded into the appropriate tertiary structure. For at least
some receptors, including the C5a receptor (Floyd et al.,
2003), GABA-A/B receptors (Balasubramanian, Teissere,
Raju, & Hall, 2004), and angiotensin 2 type I receptor
(Hansen, Theilade, Haunso, & Sheikh, 2004), oligomeriza-
tion at this stage appears to be essential for further process-
ing. Receptors must be transported to their site of action:
the plasma membrane in most cases, or the outer segment
discs in photoreceptors. The expressed receptor must
exhibit a physiologically reasonable level of basal and
pharmacologically triggered activity, and must also
undergo appropriate downregulation, usually by phosphor-
ylation and endocytosis, in order to terminate the signal
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2002). Each of these steps has presented an opportunity for
evolution to Wne-tune the signaling cascades mediated by
GPCRs, but each also presents an opportunity for failure
or dysregulation. Therefore, analysis of nonfunctional or
hyperfunctional receptors can provide insight into the
mechanism of GPCR signaling. On the other hand, it is
always diYcult to discern a speciWc reason why a particular
GPCR mutant shows aberrant function.
1.1. Mutational data from the congenital retinal dystrophies
The inherited retinal dystrophies provide a rich natural
data set for understanding how receptors act as molecular
switches. Retinitis pigmentosa (RP) is a hereditary progres-
sive blindness syndrome with an incidence of 1 in 3500 indi-
viduals (Phelan & Bok, 2000). The mode of Mendelian
inheritance of the condition—autosomal dominant or
autosomal recessive—depends on the speciWc causative
mutation. Retinitis pigmentosa is a genetically heteroge-
neous condition that has been linked to mutations in
numerous components of the phototransduction cycle,
including rhodopsin (Dryja et al., 1990a, 1990b), cGMP
phosphodiesterase subunits (Huang et al., 1995; McLaugh-
lin, Sandberg, Berson, & Dryja, 1993), the cGMP-gated cat-
ion channel (Dryja et al., 1995), and visual arrestin
(Nakamachi, Nakamura, Fujii, Yamamoto, & Okubo,
1998; Nakazawa, Wada, & Tamai, 1998). The most com-
mon locus of mutation is, however, rhodopsin, which
accounts for 1/3 of autosomal dominant cases (Phelan &
Bok, 2000).
We became interested in investigating the structural
information that can be derived from the rhodopsin muta-
tions that give rise to retinal dystrophies. More than 100
diVerent mutations in the opsin gene have been associated
with RP (Farrar, Kenna, & Humphries, 2002; Phelan &
Bok, 2000) or related milder diseases such as congenital sta-
tionary night blindness (CSNB) (Lem & Fain, 2004) and
Leber congenital amaurosis (WoodruV et al., 2003). There
have been multiple attempts to classify these mutations
according to the behavior of the mutant rhodopsin; see for
example Sung, Schneider, Agarwal, Papermaster, and
Nathans (1991), Sung, Davenport, and Nathans (1993),
Kaushal and Khorana (1994), Mendes, van der Spuy,
Chapple, and Cheetham (2005) and references therein.
Some classes of mutant rhodopsins are retained in the
endoplasmic reticulum (ER), either because of failure to
fold properly or because they are not transported to the
outer segment. Other mutants have aberrant endocytosis,
aberrant stability or post-translational modiWcation, or
enhanced coupling to transducin (Mendes et al., 2005).
Importantly, the largest class of rhodopsin mutants is still
the “unclassiWed” category, underscoring the fact that
mutant classiWcation relies on experimental data. Further-
more, the classes are not mutually exclusive, since a single
point mutation could have complex eVects on the protein’s
behavior.Despite the genetic heterogeneity of RP, it is felt that
many of the RP-associated alleles of rhodopsin are gain-of-
function mutations (Rao & Oprian, 1996; Lem & Fain,
2004). Although formally this claim would have to be tested
for each mutant on a case-by-case basis, some general
remarks can be made. Opsin is constitutively active in the
absence of retinal (Surya, Foster, & Knox, 1995; WoodruV
et al., 2003), so mutants that fail to form a chromophore
may activate transducin at a low (Melia, Cowan, Angleson,
& Wensel, 1997) but unremitting level. This has been veri-
Wed explicitly for several RP and CSNB mutants (Gross,
Rao, & Oprian, 2003a; Dryja, Berson, Rao, & Oprian, 1993;
Rao, Cohen, & Oprian, 1994; Robinson, Cohen, Zhukov-
sky, & Oprian, 1992). Certain RP mutants that associate
poorly with retinal (Mendes et al., 2005) are retained in the
ER (Stojanovic, Hwang, Khorana, & Hwa, 2003; Rajan &
Kopito, 2005; Sung et al., 1993; Sung et al., 1991) or Golgi
apparatus (Zhu et al., 2006), and at least some of these may
show a certain level of basal signaling even though they fail
to reach the cell surface. Although the ER is not a canoni-
cal site of GPCR signaling, the recently described mem-
brane estrogen receptor is a GPCR that natively signals
from the ER (Revankar, Cimino, Sklar, Arterburn, &
Prossnitz, 2005), so this mechanism may become more
widely appreciated in the future. In some mutant rhodop-
sins, the functional defect appears to be an alteration in the
cascade of photointermediates or in the light sensitivity of
the receptor (Bosch, Ramon, Del Valle, & Garriga, 2003;
Ramon, del Valle, & Garriga, 2003). As further evidence for
constitutive activity in the retinal dystrophies, we note that
when retinal degeneration results from non-rhodopsin
mutations in the photosignaling cascade, the mutation
often mimics a state of constant light activation. For exam-
ple, RP can occur when rod cGMP-gated Ca2+ channels are
constitutively closed (Dryja et al., 1995; Lisman & Fain,
1995).
1.2. Random saturation mutagenesis of the C5a receptor
Complement factor 5a (C5a), a component of the mam-
malian complement system, serves as a chemotactic factor
for neutrophils in the inXammatory response (Kohl, 2001).
Its receptor, the C5a receptor (C5aR) (Gerard & Gerard,
1991), has been investigated as a target for pharmacother-
apy in inXammatory states (Allegretti et al., 2005). Besides
its intrinsic pharmacologic interest, the C5a receptor
(C5aR) serves as a good model for family A GPCRs, which
also include rhodopsin. Human C5aR and rhodopsin
exhibit 19% amino acid identity, which is average for
GPCRs, and there are several common points between
these receptors that strongly suggest that they employ a
similar mechanism.
These similarities are both structural and functional. The
intracellular and extracellular loops of the two receptors
are similar in length, and both contain a disulWde bond
between the third transmembrane helix (TM3) and second
extracellular loop (EC2). Both possess the canonical DRY
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C5aR and ERY in rhodopsin. The role of EC2 appears to
be similar in these two receptors. Mutational data showed
that in C5aR, EC2 serves to cap the transmembrane bundle
and hold the receptor in the oV state; when the EC2-TM
binding is disrupted, the receptor becomes constitutively
active (Klco, Wiegand, Narzinski, & Baranski, 2005). Simi-
larly, the 11-cis-retinal group of rhodopsin lies in an inter-
helical crevice that is capped by EC2 (Palczewski et al.,
2000; Teller, Okada, Behnke, Palczewski, & Stenkamp,
2001; Okada et al., 2002, 2004; Li, Edwards, Burghammer,
Villa, & Schertler, 2004). More signiWcantly, it appears that
the activation of both receptors involves an increase in the
distance between TM3 and TM6. In rhodopsin, conforma-
tionally constrained mutants show that activation requires
the cytoplasmic ends of these helices to move apart (Sheikh,
Zvyaga, Lichtarge, Sakmar, & Bourne, 1996; Meng &
Bourne, 2001), whereas in C5aR, random saturation muta-
genesis (Baranski et al., 1999) and mutant cycle analysis
(Gerber, Meng, Dotsch, Baranski, & Bourne, 2001) both
support an activation-induced reorientation of TM3 and
TM6.
Our laboratory has performed extensive genetic studies
of C5aR (Baranski et al., 1999; Geva, Lassere, Lichtarge,
Pollitt, & Baranski, 2000; Klco, Nikiforovich, & Baranski,
2006; Klco et al., 2005) using random saturation mutagene-
sis of each TM helix and interhelical loop. The mutagenesis
is performed by replacing the coding sequence of the region
of interest with doped oligonucleotides to generate, for
each receptor domain, a library of approximately 105
mutant receptors. The term “saturation” is used to indicate
the entire region of interest is simultaneously and uniformly
mutagenized, not that every combinatorially possible
mutant is included in the library. We have found that a
nucleotide mutation rate of 20% leads to an optimal level of
mutational pressure in the screen. The mutant library is
screened in a yeast strain that coexpresses the C5a ligand,
which signals in an autocrine manner. In these yeast, the
presence of a functional receptor causes expression of a
selectable marker. The cDNAs encoding functional recep-
tors are isolated and sequenced.
In our screens, the vast majority of mutant receptors
are nonfunctional because their random mutations are
injurious to receptor folding or signaling. Patterns of
amino acid conservation are apparent in those receptors
that do retain ligand-dependent signaling ability despite
their random mutations. When residues are preserved in
the random mutagenesis screen, we hypothesize that they
may be essential for the receptor to be functional. This
hypothesis can be tested by point mutation. For example,
residue W102 of C5aR was unmutated in all functional
mutants isolated from our scan of the EC1 loop (Klco
et al., 2006), strongly suggesting that this residue is essen-
tial for the functioning of the C5aR, either for the struc-
tural integrity of the receptor or for its switch mechanism.
In support of this prediction, a W102A point mutation
severely impaired ligand-dependent signaling by theC5aR. In contrast, residues that are highly tolerant of
changes, such as G106 of EC1, are inferred to be non-
essential for receptor folding and signaling. One caveat of
this analysis is that essentiality is unlikely to be a black-
or-white characteristic of individual residues. The impor-
tance of residues for signaling is in reality likely to fall
along a continuum, and the essentiality of any given posi-
tion may be dependent upon the modifying eVects of
mutations at other positions. However, we have generally
found there to be a strong association between a residue’s
being preserved under random saturation mutagenesis
and its essentiality for receptor signaling.
The random mutagenesis studies of C5aR and the nat-
urally occurring RP mutations in rhodopsin provide com-
plementary views of the receptor activation mechanism.
In this study, we Wrst consider the signiWcance of overlaps
between the two data sets in terms of proposed activation
mechanisms and known receptor-activating hot spots. To
give our analysis a Wrmer structural grounding, we next
present a computational model for the structure of inac-
tive C5aR. This structure contains an internal network of
interacting essential residues. Although this network is
also likely to be present in rhodopsin, it does not appear
to be the target of RP mutations. Finally, we use energy
calculations to identify possible structural consequences
of the RP mutations.
2. Methods
2.1. Multiple sequence alignment
The amino acid sequences of human C5aR and human and bovine
rhodopsin were aligned by using the most conserved residue(s) in each
helix as a reference point (Mirzadegan, Benko, Filipek, & Palczewski,
2003). These are shown in bold in Fig. 3. Although these residues were not
perfectly conserved between C5aR and rhodopsin for all TMs, the subset
that was conserved allowed each TM to be unambiguously aligned with-
out gaps. This method has previously been used by, for example, Baldwin,
Schertler, and Unger (1997).
For Fig. 1, the extracellular and intracellular loops and amino- and
carboxy-termini of C5a and rhodopsin were also aligned so that mutations
in rhodopsin could be mapped onto corresponding positions in C5aR.
Because the loop regions are divergent, the alignment was performed by
hand with the goal of minimizing gaps while aligning charged residues and
the conserved disulWde-forming cysteine in EC2. We note that changes to
the alignment in the loop regions would have no impact on our analysis.
The complete alignment is shown in the Supplementary Data.
2.2. Molecular modeling
The 3D structure of the TM regions of C5aR was modeled by the
same energy calculation procedure that was earlier employed for rho-
dopsin (described in detail elsewhere by Nikiforovich & Marshall
(2003)). BrieXy, in the Wrst step, the TM helical fragments of C5aR were
aligned with those of rhodopsin. Boundaries of the aligned TM regions
were deWned as follows: TM1, I38–A63 (the Wrst and last residue, respec-
tively); TM2, N71–Q98; TM3, A107–V138; TM4, A150–F172; TM5,
E199–F224; TM6, R236–F267; and TM7, L281–Y300. Then, each indi-
vidual TM helix was subjected to energy minimization starting from
backbone dihedral angles corresponding to those in the rhodopsin X-ray
structure (the PDB entry 1F88 (Palczewski et al., 2000)). The TM helices
were packed together according to a previously described procedure
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procedure consisted of minimizing the sum of all intra- and inter-helical
interatomic energies in the multi-dimensional space of parameters that
included “global” parameters (those related to movements of individual
helices as rigid bodies, namely, translations along the coordinate axes X,
Y, Z and rotations around these axes TX, TY, and TZ) and “local”
parameters (the dihedral angles of the side chains for all helices). The
starting values of those angles were optimized before and after energy
minimization by an algorithm developed by us earlier (Nikiforovich,
Hruby, Prakash, & Gehrig, 1991). To decrease the number of variables in
this complicated system and to avoid problems of local convergence, the
approximation of “hard helical cores” (backbones) and “soft shells”
(side chains) for each helix was applied; the dihedral angles of backbones
(but not those of side chains) were Wxed at the values obtained by energy
calculations for the individual TM helices.
The “global” starting point for the TM bundle corresponding to the
resting state was selected by spatial alignment of TM helices onto the X-
ray structure of rhodopsin. Energy minimization that started from the
global parameters corresponding to the PDB entry 1F88 yielded a 3D
structure diVering from 1F88 by the rms value of 2.40 Å (C-atoms only)
using the energy convergence criterion of E6 1 kcal/mol. Energy calcu-
lations for RP mutants of rhodopsin were performed exactly as for rho-
dopsin itself, including modeling of the presumed light-activated state
(Nikiforovich & Marshall, 2006). The ECEPP/2 force Weld with rigid
valence geometry (DunWeld, Burgess, & Scheraga, 1978; Nemethy, Pottle,
& Scheraga, 1983) was used for all energy calculations; a distance cut-oV
of 8 Å was used for non-bonded interactions. Residues of Arg, Lys, Glu
and Asp were present as charged species with the macroscopic dielectric
constant set at the ECEPP/2 standard value of 2.0. One run of energy min-
imization for a typical TM bundle required ca. 6 h on a single-node PC
with a 2.8 GHz processor running under the Linux operating system.3. Results and discussion
3.1. Essential residues of C5aR are not preferentially 
mutated in RP
In our C5aR mutagenesis studies, we screened libraries
of mutant receptors for clones that retained the ability to
signal to downstream eVectors in the presence of ligand. A
separate screen was performed for each helix and intra- or
extra-cellular loop of the receptor. Seventy-eight out of 350
positions in C5aR were identiWed as being “preserved”;
that is, in the selected functional mutants, these positions
did not show nonconservative mutations, but rather
changed only to similar amino acids. (We included posi-
tions that exhibited one nonconservative change but no
other mutations in order to account for the possibility that
a highly dissimilar amino acid might occasionally be per-
missible in the context of other compensatory changes.)
These positions have been highlighted in blue or yellow in
Fig. 1.
Our interpretation of the preserved positions is that they
are required for receptor folding and stability or for the
activation switch mechanism. Receptors with mutations at
the preserved positions either are unstable or are unable to
switch into the “on” conformation, thus explaining their
failure to be selected in our screen. The screen does notFig. 1. Schematic diagram of C5aR with the amino terminus (extracellular) at the top and the carboxyl terminus (intracellular) at the bottom. Amino acid
positions are colored to reXect mutational data: blue denotes a residue found to be essential in random mutagenesis of the C5aR; red denotes a residue
whose homologue in rhodopsin has been implicated in retinitis pigmentosa (Mendes et al., 2005); yellow denotes positions falling into both categories.
Selected residue numbers are marked for reference purposes. (For interpretation of the references to colour in this Wgure legend, the reader is referred to
the web version of this paper.)
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constitutive activity, all functional mutants were reassessed
for signaling in the absence of ligand.
Fig. 1 also shows the reported retinitis pigmentosa muta-
tions, colored in red or yellow, mapped onto the corre-
sponding positions of the C5aR primary sequence. Yellow
color has been used to highlight residues that are both pre-
served in C5aR and mutated in RP.
Within the TM regions, each of the seven helices has been
implicated in both RP disease and C5aR activation, as judged
by the presence of both RP mutations and preserved residues
in each helix. If RP were caused mostly by inactivating or
misfolding mutations in rhodopsin, then one would expect
good overlap between these two sets of positions. The pattern
of overlap is, instead, uneven. Some helices (particularly
TM3) show abundant overlap between the data sets, whereas
others (particularly TM2) show less overlap than would be
expected by chance. We believe that the preserved positions
of C5aR are important for the receptor’s expression and fold-
ing and for its ability to serve as a functional switch; receptors
with mutations at these positions presumably have defective
folding or function since they are not identiWed in our func-
tional screens. In other words, mutations at preserved posi-
tions are normally loss-of-function mutations. The less than
complete red/blue overlap in Fig. 3 shows that mutation of a
position that is essential for C5aR folding or function is not
always, in rhodopsin, suYcient to produce the RP phenotype.
This Wnding supports the hypothesis that RP disease is
caused by (possibly small) gain-of-function changes, rather
than by loss of function, in addition to any folding or locali-
zation defects of the mutant rhodopsin.
3.2. Hot spots for constitutive activation of C5aR
Random mutagenesis of the C5aR produced several
mutants that were constitutively active in yeast. These
receptors were distinguished by the fact that they were able
to signal through the reporter pathway even in the absence
of a coexpressed C5a ligand. Since some RP mutants have
been shown to exhibit a gain of signaling function (Dryja
et al., 1993; Govardhan & Oprian, 1994; Jin, Cornwall, &
Oprian, 2003; Keen et al., 1991), and there may be many
others that also have this property, we hypothesized that
naturally occurring RP mutations would occur in the same
regions as activating mutations in our C5aR screens.
Constitutively active mutants, or CAMs, were identiWed
in the screens of TM1, TM3, TM6, and EC2 (Baranski et al.,
1999; Geva et al., 2000; Klco et al., 2005). These CAMs do
not all operate by the exact same mechanism, because there
is no mutational motif that is common to all of the CAMs.
The single CAM in the TM1 screen does not supply enough
information to deduce an activating pattern. However, dis-
tinct patterns were noted in other activating regions. In the
TM3 screen, four out of Wve CAMs included at least one of
the mutations I124N or L127Q. These two mutations alone
are suYcient to create constitutive activity (Baranski et al.,
1999) in a mechanism that would seem to involve TM6,since both side chains point towards that helix and in partic-
ular towards F251. In support of this hypothesis, a F251A
point mutation created a CAM (Whistler et al., 2002). The
most parsimonious explanation of these Wndings is that
hydrophobic interactions between I124, L127, and F251
maintain the oV state of the receptor, and mutations that
reduce this hydrophobic interaction allow constitutive
switching to the on state. Activation of the C5aR therefore
appears to involve a change in the relative position of TM3
and TM6, most likely an increase in the distance between
these two helices, as was shown for rhodopsin (Altenbach
et al., 1996; Dunham & Farrens, 1999; Farrens, Altenbach,
Yang, Hubbell, & Khorana, 1996).
To compare these data to the naturally arising muta-
tions in rhodopsin, we mapped the RP mutations onto their
cognate positions in the C5aR (Fig. 1). The random muta-
genesis screen of EC2 was unusual in that 23 out of 29 func-
tional receptors were ligand-independent. Constitutive
activity arose when multiple mutations were present at
C188 or in the ranges 181–184 and 190–192. Taken together
these data suggested that EC2 serves as a “lid” capping the
interhelical cleft, making multiple weak interactions to sta-
bilize the oV state. Disruption of several of these interac-
tions releases the EC2 lid and allows the receptor to switch
to the on state (Klco et al., 2005).
EC2 is also a hot spot for RP mutations. Of the 27 resi-
dues in the rhodopsin EC2, 11 have been found to be
mutated in RP (Fig. 1). We suggest two possible mecha-
nisms that would account for constitutive activity in rho-
dopsin EC2 mutants—although we note that these mutants’
constitutive activity has not yet been explicitly demon-
strated. First, by capping the TM bundle, EC2 may serve as
a linchpin to maintain the receptor-inactive TM3/TM6 ori-
entation; removing the linchpin allows the helices to snap
into the active conformation. Second, the 4 sheet of EC2
(residues 186–189) forms a lid that covers and stabilizes the
retinal prosthetic group (Palczewski et al., 2000). Mutations
in this region (including at C187, G188, and D190) inhibit
11-cis-retinal incorporation, thereby destabilizing the inac-
tive state, since retinal serves as an inverse agonist.
The fact that CAMs were found by mutagenizing EC2 of
C5aR, coupled with the fact that RP mutants are found in
EC2 of rhodopsin, supports the hypothesis that RP
involves a gain of rhodopsin function. However, as we
show below, energy calculations that we have performed to
model the RP mutant rhodopsin molecules suggest that the
retinal group confers some unique structural features on
rhodopsin as compared to C5aR.
3.3. Essential residues of C5aR form a network of 
interactions in the TM region
We used computational modeling of C5aR to rationalize
the existence of essential positions as well as their role in the
receptor switch mechanism. A 3D model of the TM region
of inactive C5aR was built by using as a starting point the
X-ray structure of dark-adapted rhodopsin (PDB entry
4524 I.S. Hagemann et al. / Vision Research 46 (2006) 4519–45311F88), as described in Section 2. Random saturation muta-
genesis previously identiWed 57 essential positions in the
TM helices of C5aR, as shown in Table 1. The side chains
of these residues form a speciWc network of interactions
when mapped onto the 3D model of the TM region of
C5aR (Fig. 2). Most of the essential residues are in close
Table 1
Residues in the TM regions of C5aR found to be preserved by random
mutagenesis (Baranski et al., 1999; Geva et al., 2000)
Helix Preserved residues
TM1 A40, G51, N55, V58
TM2 I70, A72, L76, N77, A79, A81, D82, L84, L87, P90, Q98
TM3 A108, C109, L112, S114, I116, S123, L126, T129, I130, D133, 
R134, L136, L137
TM4 C157, A164, L166, T168, I169, S171
TM5 A203, R206, L207, P214, L218, Y222
TM6 R236, S237, K239, L241, K242, F251, Q259, V260, S266
TM7 K280, D282, L284, V286, S287, A289, N296, P297contact with at least one of the other essential residues,
where contact is deWned as a distance of less than 5 Å
between at least one pair of atoms belonging to the side
chains of corresponding residues. Eleven residues are not in
contact with any other preserved residue, namely A40, G51,
A72, L84, Q98, L136, P214, K239, A246, S266 and A289.
The interaction network among the essential residues
can be roughly divided into two main domains, one closer
to the extracellular face of C5aR and the other closer to the
intracellular face. With the exception of the disulWde-form-
ing C109, all residues that are both preserved in C5aR and
conserved in the rhodopsin-like family of GPCRs (under-
lined and italicized in Fig. 2) are located closer to the intra-
cellular face of C5aR. In turn, this part of the network can
be divided into two clusters of residues in close contact. The
Wrst cluster contains residues N55, V58 (TM1), L76, N77,
A79, A81, D82 (TM2), N296 and P297 (TM7), and the sec-
ond cluster contains residues S123, L126, T129, I130, D133,Fig. 2. Network of interactions between the preserved residues in C5aR. Residues are shown as semi-transparent balls. TM helices are shown as one-line
ribbons. Close contacts between the side chains are shown as sticks connecting the balls. Residues that are conserved in the rhodopsin family of GPCRs
are labeled in underlined italics. Transmembrane helices are color-coded: TM1 in cyan, TM2 in red, TM3 in magenta, TM4 in yellow, TM5 in white, TM6
in blue, and TM7 in green. The extracellular face of the receptor is at the top. (For interpretation of the references to colour in this Wgure legend, the reader
is referred to the web version of this paper.)
A40
G51
N55
V58
Q98
P90
L87
L84
D82
A81
A79
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L76
A72
L284
D282
V286
S287
A289
N296
P297
C109
A108
P113
L112
S114
I116
S123
L126
T129
I130
R134
D133
L136
S266
V260
Q259
F251
A249
V248
A246
K242
L241
K239
S237
R236
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I169
T168
L166
A164
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A203
L207
R206
P214
L218
Y222
I.S. Hagemann et al. / Vision Research 46 (2006) 4519–4531 4525R134 (TM3), C157 (TM4), L218, Y222 (TM5), L241, K242,
V248, A249 and F251 (TM6). The two clusters are con-
nected through a weak interaction between N77 and C157
and by much more strong interactions of F251 (TM6) with
S123 and L126 in TM3 as well as with N296 in TM7.
The network depicted in Fig. 2 represents a system of
inter-residue interactions necessary for maintaining proper
functioning of the C5a receptor; any changes in the net-
work lead to either impaired function or hyper-functional-
ity, such as in constitutively active mutants. Indeed, Fig. 2
highlights the unique role of the side chain of F251 in main-
taining the network of interactions between the preserved
residues in C5aR. The F251A mutant is known to be a
strong constitutively active mutant (Whistler et al., 2002).
Moreover, the side chain of F251 is in close contact not
only with the preserved S123, L126 and N296, but also with
the side chains of residues L127 (TM3), F254 (TM6) and
N292 (TM7). Placement of a polar side chain at L127 can
give constitutive activity as in the I124N/L127Q (“NQ”)
mutant (Whistler et al., 2002); also, modiWcations of F254
lead to constitutively active mutants (Nikiforovich, Sen, &
Baranski, 2006). Combined, these Wndings suggest that resi-
dues in the vicinity of F251 form a hot spot for designing
new constitutively active mutants of C5aR.
3.4. The network of essential residues is not preferentially 
mutated in RP
We chose to focus on the TM regions of C5aR because
these are highly conserved between GPCRs. Multiple
sequence alignments of 270 members of GPCR family A
allowed the most conserved residues to be identiWed (Mir-
zadegan et al., 2003); these positions, highlighted in bold in
Fig. 3, are largely conserved from rhodopsin to C5aR and
allow us to align the TM helices. In addition, as described,
random saturation mutagenesis data allowed us to identify
a network of essential residues in C5aR. It is reasonable to
suppose that rhodopsin contains a similar network, because
32 of the 35 TM residues most highly conserved in family A
GPCRs are conserved between rhodopsin and C5aR
(Fig. 3).
When we mapped the known RP mutations onto the
structure of rhodopsin, we found that they did not prefer-
entially coincide with the presumed network of essential
positions. On the contrary, out of 39 TM RP mutations
in rhodopsin, only 13 are in positions that correspond to
essential residues of C5aR (see Fig. 3). Mapping of the
RP mutations onto the 3D structure of the TM region of
rhodopsin (Fig. 4, right) shows that there are much less
close contacts between the side chains of RP mutant resi-
dues than there were between the preserved residues.
Only a few inter-helical contacts are observed between
the RP positions in the X-ray structure of rhodopsin, spe-
ciWcally L40-T289 (TM1-TM7), M44-T94 (TM1-TM2),
F44-K296 (TM1-TM7), L125-P215/L216 (TM3-TM5),
R135/Y136-C222 (TM3-TM5), and C167-M207/H211
(TM4-TM5).3.5. Energy calculations deWne four diVerent classes of 
ionogenic RP mutations
3.5.1. Outwardly directed ionogenic RP mutations
We have shown that RP does not arise from simple dis-
ruption of the receptor-stabilizing network of inter-residue
interactions. We asked whether we could deduce any other
common structural ground for the mutations that are
observed in RP. According to the database maintained at
http://www.retina-international.com, most of these muta-
tions (23 out of 39) are replacements by potentially charged
residues, namely R, K, D, or E (shown in bold in Fig. 5).
For some of these positions (L46, P53, L216, and G270),
Fig. 3. Sequence alignment showing essential residues in C5aR (blue) and
positions of RP mutations in rhodopsin (red). Residues conserved in the
rhodopsin family of GPCRs are in bold (Mirzadegan et al., 2003); TM
helices are underlined. (For interpretation of the references to colour in
this Wgure legend, the reader is referred to the web version of this paper.)
the side chains are directed out of the TM bundle, toward
the hydrophobic membrane lipids. Our modeling procedure
does not speciWcally address interactions with lipids, but in
general, charged side groups should not be tolerated in the
lipid bilayer and could potentially destabilize the receptor.
Alternatively, outward-pointing charged residues could
interfere with oligomerization of receptors. Work by the
Palczewski group (for example Filipek et al. (2004) & Foti-
Fig. 5. RP mutations in the TM regions of rhodopsin; bold type indicates
mutations to the charged residues R, D, E, or K. At positions where
bovine and human rhodopsin are nonidentical, the bovine residue is indi-
cated before the human one. When a preserved residue of C5aR was pres-
ent at the corresponding position, that residue is indicated. Boxes are used
to categorize the RP mutations: red, mutations aVecting interactions with
retinal; blue, general structural mutations. (For interpretation of the refer-
ences to colour in this Wgure legend, the reader is referred to the web ver-
sion of this paper.)adis et al. (2006, 2003, 2004)) has suggested that rhodopsin
dimers or oligomers are the functional unit and that signal-
ing by monomers occurs less eYciently; the tightness of
receptor packing appears to be important for determining
the rate of phototransduction (Calvert et al., 2001). In some
studies, dilution of wild-type rhodopsin into detergent
micelles, so that only monomeric rhodopsin is present,
results in receptors that signal at a rate close to that of wild-
type (Hofmann, 2006), arguing against an essential role for
rhodopsin dimerization in signaling; but in other studies,
rhodopsin monomers signal more slowly than oligomers
(Jastrzebska et al., 2004). Thus it appears likely, but not cer-
tain, that rhodopsin density is important for signaling.
One interesting possibility is that rhodopsin–lipid or
rhodopsin–rhodopsin contacts might help to maintain the
oV conformation. A packing-related rhodopsin regulatory
mechanism could explain the rod outer segment’s unusual
membrane composition (Boesze-Battaglia & Schimmel,
1997). It seems reasonable to suppose that dense rhodopsin
packing places inwardly directed, stabilizing forces on each
receptor monomer and reduces the basal activity of the
receptor. Outwardly directed charged side chains would
electrostatically repel adjacent receptors or lipids and
reduce these stabilizing forces, thus giving rise to a weakly
constitutively activated receptor. If this mechanism were
operative, then RP mutations might arise at positions that
interact directly with membrane lipid molecules. In a recent
simulation run on the IBM Blue Gene supercomputer,
phospholipids containing both stearic acid and the -3
polyunsaturated fatty acid docosahexaenoic acid (DHA)
were allowed, along with cholesterol, to assume their pre-
ferred orientations around rhodopsin (GrossWeld, Feller, &
Pitman, 2006). P53 of rhodopsin was found to be one of the
residues that preferentially interacted with cholesterol and4526 I.S. Hagemann et al. / Vision Research 46 (2006) 4519–4531
Fig. 4. Preserved residues in C5aR (left, the same as in Fig. 2) and positions corresponding to RP mutations in rhodopsin (right) mapped onto the 3D
structure of rhodopsin. Color codes, sticks showing contacts and projections are the same as in Fig. 2. (For interpretation of the references to colour in this
Wgure legend, the reader is referred to the web version of this paper.)
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Although amino acids L46 and L216 did not preferentially
interact with membrane lipids, mutations at these positions
could conceivably act by a longer-range mechanism.
3.5.2. RP mutations repositioning the charged side chain of 
E113
After examining outwardly directed ionogenic muta-
tions, we performed energy calculations to derive 3D mod-
els of the resting state of the 14 other ionogenic RP or
CSNB mutants, namely L40R, G51R, T58R (TM1); V87D,
G89D, G90D (TM2); G109R, G114D, L125R (TM3);
A164E, C167R (TM4); M207R, H211R (TM6); and A292E
(TM7); we also considered here the non-ionogenic muta-
tion T94I in TM2 since this mutation is closely allied with
G90D (Gross et al., 2003a, Gross, Xie, & Oprian, 2003b). In
each of these receptors, the mutant side chain is directed
inward toward the helical bundle and lies in the vicinity of
retinal, in most cases closer than 10 Å (Fig. 6). Our calcula-
tions were intended to determine whether these mutations
had any eVect on the retinal group’s environment, which in
turn is known to be important for rhodopsin activation.
Side chains of the residues in positions 90, 94, and 292
are in the near vicinity of the unprotonated side chain of
Fig. 6. Mapping of RP mutations on the 3D model of the TM region of
rhodopsin. Mutations are shown as semi-transparent balls colored either
in red (for replacements by negatively charged side chains) or in blue (pos-
itively charged side chains). Side chains of residues D83, E113, E122,
E134, R135, N302 and K296 with cis-retinal attached are shown as ball-
and-stick models. TM helices are shown as one-line ribbons. The extracel-
lular face of the receptor is at the top. (For interpretation of the references
to colour in this Wgure legend, the reader is referred to the web version of
this paper.)E113. This residue is involved in a crucial salt bridge with
the positively charged nitrogen atom of the SchiV base con-
necting the side chain of K296 to cis-retinal. This interac-
tion is believed to stabilize the dark-adapted state of
rhodopsin (Cohen, Oprian, & Robinson, 1992; Robinson
et al., 1992). According to energy calculations, the side
chain of E113 may nearly equally populate conformations
featuring either the salt bridge or a hydrogen bond between
the -carboxyl of E113 and the hydroxyl of the side chain
of T94. The latter, in turn, may switch to form a hydrogen
bond with the backbone carbonyl of G90. Previous work
with rhodopsin mutants at T94 (including T94D) supports
an important role for the hydroxyl group of T94 in stabiliz-
ing the electrostatic network around the SchiV base linkage
in rhodopsin (Ramon et al., 2003). In mutants G90D and
A292E, the electrostatic repulsion between the negatively
charged side chains of E113 and D90/E292 forces the side
chain of E113 away from retinal, which disrupts the inter-
action stabilizing the resting state of rhodopsin. Similarly,
the side chain of E113 is driven away from retinal in the
T94I mutant; in this case, however, the cause is steric hin-
drance due to replacement of the hydroxyl in T94 by a
bulky aliphatic group in I94. All three mutants are known
as constitutively active mutants of opsin and are associated
with CSNB (Dryja et al., 1993; Gross et al., 2003a, 2003b).
A similar spatial position of the E113/Q113 side chain
was found by energy calculations of two known pro-
nounced constitutively active mutants of rhodopsin,
namely G90D/M257Y and E113Q/M257Y (Nikiforovich &
Marshall, 2006). The same changes of spatial orientation of
the negatively charged E113 side chain may occur also in
mutants V87D, G89D, G114D and G109R. Movement
away from retinal is facilitated in the former three mutants
by electrostatic repulsion between negatively charged side
chains, and in the latter one by electrostatic attraction
between the oppositely charged E133 and R109 (Fig. 6).
Though an alternative conformation of the E113 side chain
is not excluded in these mutants (as in the constitutively
active mutants discussed above), interaction of E113 with
retinal is eVectively weakened.
3.5.3. RP mutations strengthening the TM3–TM5/TM4 
interaction
Another group of mutants is composed of L125R,
C167R, M207R, H211R and A164E. According to energy
calculations, the main diVerence between these mutants and
wild-type rhodopsin is in strengthened interactions between
TM3 and TM5/TM4 because of the additional electrostatic
attraction between the positively charged residues in TM5/
TM4 and the negatively charged E122 (Fig. 6). Repulsion
between E164 and E122 also eVectively strengthens interac-
tion between TM3 and TM5. This, in turn, may weaken
interactions between TM3 and TM6, facilitating conforma-
tional transition to the activated state of rhodopsin. It
should be noted, however, that our energy calculations for
all RP mutants did not Wnd a signiWcant energetic prefer-
ence for the presumed activated state of the TM region of
4528 I.S. Hagemann et al. / Vision Research 46 (2006) 4519–4531the mutants (such as that deduced for rhodopsin from spec-
troscopic data (Hubbell, Altenbach, Hubbell, & Khorana,
2003)), as was found earlier for the strong constitutively
active mutants G90D/M257Y and E113Q/M257Y (Nikif-
orovich & Marshall, 2006).
The 12 RP mutants described above were produced by
replacement of residues in positions close to retinal, namely
87, 89, 90, 94 in TM2; 109, 114, 125 in TM3; 164 and 167 in
TM4; 207, 211 in TM5; and 292 in TM7. Since the retinal
group and its charged SchiV base are features unique to
rhodopsin, there is no reason to expect that other receptors
will be activated or, on the contrary, injured by mutations
in this same spatial domain. These positions may be
regarded as those important for stabilization of the oV state
speciWcally in rhodopsin; mutations in the corresponding
positions may not be of the same importance in other
GPCRs. Indeed, only Wve out of the 12 corresponding resi-
dues in C5aR were found to be preserved in our random
mutagenesis screen, namely A108, P113, A164, R206 and
V286 (see Fig. 5, red boxes).
3.5.4. Helix-destabilizing RP mutations
A fourth set of RP mutations appear to cause overall
structural instability of the seven-transmembrane bundle.
The RP mutations G51R and T58R target positions that
are located far from retinal but close to the residue D83
that is highly conserved throughout the rhodopsin-like
family (Mirzadegan et al., 2003). Our energy calculations
show that electrostatic attraction between R51/R58 and
D83 inXuences the balance of interactions between con-
served residues D83 in TM2 and N302 in TM7; this pair
was shown to interact in many GPCRs (Cook et al., 1993;
Donnelly et al., 1999; Flanagan et al., 1999; Perlman et al.,
1997; Sealfon et al., 1995; Zhou et al., 1994). The impor-
tance of this cluster is independent of any contribution
from the 11-cis-retinal group. One can assume that residues
in the corresponding positions of other GPCRs would be
likely to be detected in random mutagenesis as the pre-
served ones; indeed, this was the case for C5aR (residues
G51 and V58). Destabilization of the resting state in this
group of the RP mutants may be, therefore, of a more gen-
eral nature and not speciWc for visual pigments. The same
may be true for the non-ionogenic RP mutants with
replacements of proline residues within TM helices by non-
prolines and vice versa—since proline is noted for its helix-
breaking properties—or for mutations disrupting the
conserved disulWde bridge (C110Y, L131P, P171L, P215T,
and T289P). Essential residues were found in or near the
corresponding positions of C5aR in six out of seven of
these cases (Fig. 5, blue boxes).
The RP mutation C222R occurs in the vicinity of the
conserved ERY fragment, but our energy calculations for
this mutant did not Wnd signiWcant changes in the spatial
orientation of the side chains of E134 and R135. Also, the
results of molecular modeling did not suggest why muta-
tion L40R (corresponding to the preserved residue A40 in
C5aR) leads to functional impairment. Generally, however,one may conclude that RP mutations inXuencing interac-
tions close to retinal, and, therefore, speciWc for rhodopsin,
are unlikely to correspond to the preserved residues of
other receptors such as C5aR, as determined by random
mutagenesis. On the other hand, RP mutations targeting
residues with a more general structural role in the receptor
are likely to correspond to essential residues of other
GPCRs—as we observed in our screens of the C5aR.
4. Conclusions
In this article we have compared two independent sets of
GPCR mutations: one from the naturally arising retinitis
pigmentosa and night blindness mutations in rhodopsin,
another from random saturation mutagenesis of the C5a
receptor. These data sets indicate, in diVerent ways, residues
that are essential for receptor function. Structural analysis
of both sets, performed by molecular modeling, allowed the
mutational data to be rationalized in several ways. EC2 of
C5aR is the site of many activating mutations, and retinitis
pigmentosa mutations are also common in EC2. When the
essential residues of C5aR are mapped onto a structural
model, they form an interacting network that stabilizes the
receptor. To the extent that C5aR and rhodopsin are struc-
turally related, this network should also be present in rho-
dopsin; however, the RP mutations do not preferentially
map to the network, suggesting that RP does not arise from
wide-ranging structural destabilization of the receptor.
Many RP mutations introduce residues with ionizable
side chains. Computational modeling of individual charge-
introducing RP mutations was performed to identify their
structural consequences for rhodopsin. Most of the RP
mutations cause disruption of interactions between retinal
and the rest of the molecule in the dark-adapted state, and,
therefore, are speciWc for rhodopsin. In general, these posi-
tions were not found to be preserved in our screens of the
C5aR. In our calculations, however, some mutations
appear to be important for overall receptor structural
integrity, including G51R, T58R, and mutations involving
proline such as Ll31P, P171L, P215T, and T289P. The cor-
responding positions were preserved in the genetic screens
of C5aR, suggesting that these components of the receptor-
stabilizing network are shared between C5aR and
rhodopsin.
Taken together, our Wndings suggest that GPCRs,
including rhodopsin, have considerable overlap in their
mechanisms of action. However, rhodopsin has evolved
additional molecular mechanisms, centered on the retinal,
that may serve to minimize the basal activity of the recep-
tor. The need for this extra safeguard becomes evident
when one considers that slight increases in activity can lead
to retinitis pigmentosa or congenital night blindness.
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